Lysophosphatidylserine stimulates chemotactic migration of colorectal cancer cells through GPR34 and PI3K/Akt pathway.
Lysophosphatidylserine stimulates chemotactic migration of colorectal cancer cells through GPR34 and PI3K/Akt pathway.
复制标题
DOI:
--
复制
发表时间:
2014-10
影响因子:
2
通讯作者:
Yuuki Iida;Nelson H Tsuno;J. Kishikawa;Kensuke Kaneko;K. Murono;K. Kawai;T. Ikeda;S. Ishihara;H. Yamaguchi;E. Sunami;J. Kitayama;Y. Yatomi;Toshiaki Watanabe
中科院分区:
文献类型:
--
作者:
Yuuki Iida;Nelson H Tsuno;J. Kishikawa;Kensuke Kaneko;K. Murono;K. Kawai;T. Ikeda;S. Ishihara;H. Yamaguchi;E. Sunami;J. Kitayama;Y. Yatomi;Toshiaki Watanabe
BACKGROUND Lysophosphatidylserine (lysoPS) is a type of lysophospholipid mediator, which is involved in allergic conditions and tumor progression. We investigated the physiological function of lysoPS on colorectal cancer (CRC) cell lines, as well as the involved receptor and signaling pathways. MATERIALS AND METHODS Expression of lysoPS receptors on six cell lines was examined by reverse transcription-polymerase chain reaction (RT-PCR). The physiological functions of lysoPS were investigated, and experiments using small interfering RNA (siRNA) or inhibitors of the signaling pathways were conducted. RESULTS Among the three lysoPS receptors, GPR34 was highly expressed on all cell lines. LysoPS stimulated the chemotactic migratory ability. Wortmannin inhibited the migratory ability, as well as the GPR34 knock-down, strongly suggestive of the involvement of this receptor in the PI3K/Akt pathway. CONCLUSION The involved receptor and pathways in the migratory ability in response to lysoPS was demonstrated, which opens premises for targeting as a new strategy for prevention and treatment of colorectal cancer.